Extract from previous announcement
"The goal of the relationship between Select-Tel and the Burnet
Institute is to fund the development and commercialisation of highly
promising research & development ("R&D") projects, initially in the
fields of hepatitis diagnostics and vaccines, and antivirals against
rhinoviruses (common cold) and enteroviruses. Included is a business
development program for a market -ready hepatitis E diagnostic
product aimed at large markets in Asia. As part of the relationship,
Select-Tel will gain a right of first review and commercialisation
over a selected range of other research being conducted at the Burnet
Institute.
The key terms of the MOU between the company and the Burnet Institute
include the following:
- Select-Tel will establish two subsidiary project companies to fund
and manage existing Burnet Institute R&D projects in the fields of
hepatitis diagnostics and vaccines, and antivirals for
rhinovirusesand enteroviruses;
Yes the company has extensive research into rhinovirus and SARS is thought to be a very similar virus.
I have some SLT which is why I have picked up this connection......I don't think anyone else has noticed this yet
- Forums
- ASX - By Stock
- SLT
- sars no one has picked this up yet
sars no one has picked this up yet
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)